Literature DB >> 1839552

Recognition of respiratory syncytial (RS) virus proteins by human and BALB/C CD4+ lymphocytes.

J J Anderson1, J A Harrop, H Peers, T Turnbull, G L Toms, R Scott.   

Abstract

Lymphocyte proliferation assays were used to determine the ability of human and BALB/c T-lymphocytes to recognise and respond to in vitro challenge with purified preparations of four respiratory syncytial (RS) virus proteins. Human peripheral blood lymphocytes (PBLs) collected from adult donors as well as primed BALB/c mouse splenocytes each responded specifically to challenge with intact RS virus and preparations of the fusion (F), attachment (G), 23 kilodalton (23K), and 34K phospho- (P) proteins of the virus. F protein was recognised most frequently by human PBLs, and elicited higher levels of response than equivalent concentrations of the other protein preparations examined. The human PBL proliferative responses elicited by in vitro challenge with intact virus antigen as well as with each of the four protein preparations were found to be confined to the CD4+ T-helper (Th) sub-population of lymphocytes. However, proliferative responses to intact virus and F protein were found to be accompanied by only modest and inconsistent production of Interleukin-2 (IL-2). Finally, no evidence was obtained to indicate that any of the challenge antigens employed in this study were intrinsically mitogenic, as neither naive human cord blood lymphocytes, nor un-primed BALB/c mouse splenocytes proliferated when challenged with intact RS virus or with F, G, 23K, or P protein preparations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839552     DOI: 10.1002/jmv.1890350305

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  T cell redistribution kinetics after secondary infection of BALB/c mice with respiratory syncytial virus.

Authors:  J L Kimpen; P L Ogra
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

Review 2.  Immunopathological mechanisms in respiratory syncytial virus disease.

Authors:  P J Openshaw
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.

Authors:  R Arnold; B König; H Galatti; H Werchau; W König
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

4.  Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.

Authors:  R Arnold; B Humbert; H Werchau; H Gallati; W König
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

5.  Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.

Authors:  Grada M van Bleek; Martien C Poelen; Robbert van der Most; Humphrey F Brugghe; Hans A M Timmermans; Claire J Boog; Peter Hoogerhout; Henny G Otten; Cécile A C M van Els
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.